Wikidata

(Q48107987)

English

Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial.

scientific article

In more languages

Statements

title
Efficacy and Safety of Once-Weekly Semaglutide Versus Exenatide ER in Subjects With Type 2 Diabetes (SUSTAIN 3): A 56-Week, Open-Label, Randomized Clinical Trial (English)
1 reference
stated in
Europe PubMed Central
PubMed publication ID
29246950
reference URL
https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:29246950%20AND%20SRC:MED&resulttype=core&format=json
retrieved
7 April 2020

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q48107987&oldid=2145724299"